[Cardiovascular risk calculators for people living with human immunodeficiency virus]

Area of Science:

• Cardiology
• Infectious Diseases
• Public Health

Background:

• Antiretroviral therapy (ART) has improved life expectancy for people with human immunodeficiency virus (HIV).
• Increased cardiovascular disease (CVD) risk is a significant concern in the HIV population.
• This risk stems from traditional factors, chronic inflammation, and ART's metabolic effects.

Purpose of the Study:

• To review the epidemiology of cardiovascular disease in people living with HIV.
• To discuss the limitations of current cardiovascular risk calculators in this population.
• To guide clinical decision-making for managing CVD risk in HIV.

Main Methods:

• Literature review of epidemiological studies on CVD in HIV.
• Analysis of existing cardiovascular risk assessment tools.
• Discussion of the impact of HIV infection and ART on cardiovascular health.

Main Results:

• CVD is a leading cause of morbidity and mortality in people with HIV.
• Traditional risk calculators may underestimate CVD risk in the HIV population.
• Specific factors related to HIV and its treatment contribute to elevated cardiovascular risk.

Conclusions:

• Managing cardiovascular risk is crucial for improving long-term outcomes in people with HIV.
• Further research is needed to refine risk prediction models for this population.
• A comprehensive approach considering HIV-specific factors is essential for cardiovascular care.